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DYNAMIC REGULATION OF ERYTHROPOIESIS: A COMPUTER
MODEL OF GENERAL APPLICABILITY
By
Joel 1. Leonard
ABSTRACT
A mathematical model for the control of erythropoiesis has been
developed based on the balance between oxygen supply and demand at a
renal oxygen detector which controls erythropoietin release and red cell
production. Feedback regulation of tissue oxygen tension is accomplished
by adjustments of hemoglobin levels resulting from the output of a renal-
bone marrow controller. Special consideration was given to the deter-
minants of tissue oxygenation including evaluation of the influence of
blood flow, capillary diffusivity, oxygen uptake and oxygen-hemoglobin
affinity. A theoretical analysis of the overall control system is pre-
seoted including: a) dynamic and steady-state responses, b) sensitiv-
ity analysis to determine relative importance of parameters and their
influence on model behavior, c) properties of the model as a proportional
controller, d) analysis of steady-state errors, and e) effectiveness
of feedback regulation. Computer simulations of altitude hypoxia, red cell
infusion hyperoxia, and hemolytic anemia demonstrate validity of the model
for general human application in health and disease.
INTRODUCTION
Systems analysis has been shown to be a highly useful technique for
understanding complex physiological processes, especially those under feed-
back control (Riggs, 1970). The systems analysis approach, as used here,
involves integrating the primary physiological mechanisms, both those that
are known and those postulated, into a single framework - a mathematical
model - which represents the system under stud y . Computer simulations
performed with these models often reveal theoretical inconsistencies,
model refinements, new hypotheses, the design of new experiments or the
format for reprocessing existing data.
The control of erythropoiesis is amenable to a modeling approach as
demonstrated by a variety of investigators. These models have ranged from
conceptual, qualitative feedback schemes (Fisher, et al, 1975; Erslev, 1975)
to more detailed mathematical descriptions (Hodgson, 1970), some of which
have led to computer simulation models (Mylrea R Abbrecht, 1971; Guyton,
et al, 1972). Quantitative models have been developed for different aspects
of erythropoiesis regulation including ferrokinetic models (Cavill & Ricketts,
1974; 6erzuini, et al, 1978), and those describin g
 the control of stem cell
production (Mackey, 1978; Lajtha, 1962; Kretchmar, 1966).
A limited number of models are available which integrate the entire
feedback circuit in sufficient detail to permit quantitative simulation of
a diversity of hematological stresses directly affecting oxygen transport,
tissue oxygenation, erythropoietin release, and red cell production. Hodgson
(1970) has proposed such a model, but apparently has not implemented it for
computer use nor performed the studies necessary for validation. An al gor-
ithm capable of predicting red cell mass changes by feedback processes was
coupled to a much larger model of circulatory and fluid control (Guyton,
et al, 1972), but it providRd only a gross representation of the renal-bone
F	 narrow axis and failed to recognize renal oxygenation as a major controlI
F
	
	
element. The most complete simulation model previously developed is that
of Mylrea and Abbrecht (1971) which was validated for a single stress -
altitude hypoxia in mice. No study presently exists of a fully documented
i	 model suitable for general human application.
zThe model proposed in this study has incorporated some of the best
features of the three models discussed in the last paragraph and has exten-
ded them to include the following unique capabilities: a) a more realistic
representation of renal tissue oxygenation, b) explicit representation of
	 1
a large number of physiologically meaningful parameters to facilitate hypo-
thesis testing and simulation of a large number of stress situations, c) an
adjustable affinity of oxygen for hemoglobin, d) validated simulations of
the human response, and e) computer software designed for non-expert user
convenience including conversational mode of operation on remote terminals
with graphic capability. While our original objective was to formulate a
model to examine the loss of circulating red cell mass in astronauts return-
ing from spacefl'g;it (Kimzey, et al, 1976; Leonard, 1975), the
pre3ent version has developed into a model of more general applicability.
A model claiming to represent the overall control of eryth. ,opoiesis should
be capable of simulating behavior to a wide variety of normal hematological
stresses and pathological disorders.	 It is the purpose of this study to
describe the model, review its limitations, demonstrate its diverse capa-
bility, and examine some of the control system characteristics of erythro-
poiesis regulation.
GENERAL MODEL DESCRIPTION
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The model which forms the basis of this study was formulated to inves-
tigate the relative influence of the controlling factors of erythropoietis
on total red cell mass. Elements in the feedback regulation loop which
have been incorporated into the model are shown schematically in Figure 1.
The formulation was based on the generally accepted conce p t that the over-
all balance between oxygen supply and demand regulates the release of a
hormone, erythropoietin, from renal tissues sensitive to oxygen tension
levels and that this substance in turn controls bone marrow red cell pro-
duction (Adamson & Finch, 1975; Fisher, et al, 1975; Jacobson, et al, 1951).
The amount of oxygen delivered to the tissue is account-d for in the
model by the combined influence of several facto rs: hemoglobin concentra-
tion, lung oxygenation of hemoglobin, blood flow and oxygen-hemoglobin
affinity (Finch & l.enfant, 1972).
	 From this arnount of oxygen, a certain
fraction is extracted by the tissue depending on the oxygen demand para-
meter. Oxygen enters the cellular spaces by diffusion along an oxygen
tension gradient between the venous capillaries and the cell (Hodgson, 1970).
Decreasing the oxygen supply in relation to the demand reduces tissue oxygen
tension which is, in effect, monitored by a local oxygen detector (Beutler,
1969) and results in increased rates of erythropoietin release (Krantz and
Jacobson, 1970). Erythropoietin is released into the general circulation
and its final plasma concentration is determined by its rate of release,
volume of distribution and the rate at which it is metabolized (Reismann,
et al,1965 ), the latter being represented ;n the model by the hormone
plasma half-life. The target organ for erythropoietin is the bone marrow.
The production rate and release of red cells in the model is determined by
the plasma erythropoietin concentration (Van Dyke & Pollycove, 1962). A
time delay exists between marrow stimulation and red cell release (Harris
& Kellermeyer, 1970). Splenic destruction of cells is represented in the
model by a life-span parameter. Hemoglobin concentration in blood is based
on the addition of new cells to existing cells and plasma.
In terms of control system theory (Milhorn, 1966) the controlled system
includes the elements of redistribution of new cells, lung oxygenation, blood
dtrans port and tissue oxygen extraction, while the co-rtroller astem con-
sists of erythropoietin release, marrow red cell production and splenic
destruction. The hematocrit (or hemoglobin level) may be considered to be
thertp • mary feedback _uantity and the level of tissue oxygenation can be
taken as the directly controlled variable.
It is known that red cell production is modulated by factors other
than those considered here. These include iron levels (Finch, et al, 1971),
hormones other than erythropoietin (Peschle, et al , 1975 ), neural stimula-
tion (Baciu, 1970), as well as inhibitors and activators of erythropoietin
(Gordon & Zaniani, 1970). While it may be desirable to include these effects
in future model applications, quantitative information regarding them is
{p resently lacking or the need for their inclusion is not yet warranted. It is
also important to note that overall oxygen transport is under the control of
homeostatic mechanisms other than the erythropoietis system. Thus, some of
the fixed parameters of the wodel such as blood flow, capillary diffusivity,
arterial oxygen tension, plasma volume and oxy-hemoglobin affinity can be
considered variable elements of circulatory, ventilatory, biochemical and
fluid regulatory feedback mechanisms which are beyond the scope of the present
model's design objectives. Larger models which incorporate many of these
features are available ind these have been shown to be compatible with an
erythropoietis subsystem model (Guyton, et al, 1972). While these mech-
anisms are not included explicitly in the present model, their influence
can be tested, in most cases, by known secondary effects on existing model
elements.
.y
5MA.THFMATICAL DESCRIPTION OF MODEL
Oxygenation of Blood
The oxygen concentration of arterial blood (neglecting oxygen dissolved
in plasma) following passage through the lungs, can be expressed as the pro-
duct of the carrying capacity of a gram of hemoglobin (CHbO; i.e. 4 moles 02
per mole Hb), times the hemoglobin concentration (Nb), times the fractional
degree of oxy-hemoglobin saturation (S a0). We have found it convenient to
use hematocrit rather than hemoglobin concentration as an index of red cell
concentration in blood. Thuse quantities are related by the mean corpuscular
hemoglobin concentration, such that MCHC = Hb/Hct.	 Therefore, for arterial
blood:
Ca 0 = Sa 0 x Hb x CHbO = Sa 0 x Hct x MCHC x CHbO 	 (1)*
At full hemoglobin saturation, S a o = 1.0 and E-,uation (1) will then repre-
sent the maximum oxygen ca p- Tying capacity of blood at a given hematocrit.
In most instances the parameters MCHC and CHbO 0 1 1 be invarient, so that
the arterial oxygen concentration is influenced only by the hematocrit and
hemoglobin saturation. 	 In practice, the arterial oxygen tension (P a 0) is
assigned a value* and a corresponding value of S ao is determined from the
oxy-hemoglobin equilibrium curve (OEC), an operation which can be expressed
in functional form as:
S ao = OEC(Pa0)
	
(2)
Oxygen  Delivery at Tissues
Oxygen transport at the tissue level is schematically represented in
Figure 2.	 In tile present model the tissue of concern is taken to be the
erythropoietin producing cells known to be located primarily within the
kidneys. It has been assumed that the oxygen sensor as well as sites of
erythropoietin production are responsive to the mean oxygen tension of the
* See Table I for symbol definition, units and normal values.
6kidneys. This assumption permits tissue oxygen tension to be derived from
do oxygen balance using blood flows, arterio-venous oxygen concentrations,
oxygen consumption and transcapillary diffusion resistances common to the
kidneys which are considered to he a homogenous tissue.
The elements of tissue oxygenation were determined using a two-phase
model consisting of capillary blood and tissue fluid (Middleman. 1972). It
is assumed that the blood compartment is well-mixed with an oxygen partial
pressure (P v0) equal to that in the venous outflow. Oxygen diffuses prom
blood to tissue along a gradient of oxygen partial pressure (P v0 - Pt0)
where P 
t 
0 is the oxygen tension of the homogenous tissue. The amount of
oxygen unloaded from the blood is given by the difference in oxygen concen-
tration between arterial and venous blcod (C a 0 - C v0). At equilibrium the
rate of oxygen transfer to the tissues is identical to the tissue oxygen
consumption (V M ) as well as the unloading of blood oxygen as determined by
the arterio-venous oxygen concentration, that is:
Q x (Ca 0 - C v0) = Kd x (P v0 - P t 0) = V 	 (3)
rate of oxygen
	
rate of oxygen
unloading	 diffusion
where Q is the rate of regional blood flow and K  is the diffusive trans-
fer coefficient between blood and tissue.
The venous partial pressure may be obtained by solving Equation (3)
for Cv0,
CVO = C 
a 
0 - Vm/Q	 (4)
then computing venous hemoglobin saturation from a forriulation analogous
to Equation (1),
S 
v 
0 = C v0/(Hct x MCHC x (;HbO)	 (5)
and determining P 
v 
0 from the OEC, expressed in functional fonrn 3s:
P 
v 
0 = OEC(S v 0)	 (6)
It
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Tissue oxygen tension can now be derived from Equation (3) as:
P 
t 
0 = P 
v 
0 - Vm/Kd	(7)
The assumption of steady-state in this formulation implies rapid
equilibration of oxygen in the fluid phase and is not meant to suggest a
constant tissue oxygen tension during the simulation of an erythropoietic
disturbance. Since the erythropoietic process itself has been modeled
dynamically (see below), the hematocrit will be time-varyinq until red
cell production achieves its own steady-state. 	 In this model, the he ►►►a-
tocrit is, therefore, a major influence on alterations in tissue oxygen
tension.	 In addition, other quantities in this algorithm (i.e. P a 0, Vm ► ,
Kd , P50, Q) are non-regulatory parameters and can also influence tissue
oxygen tension if they are manually altered.
Er ty hropo iet i n Production and Distribution
Erythropoietin release is assumed to be governed by the tissue oxygen
tension. A limited number of studies (Hodgson, 1970; Mylred R Abbrecht,
1971, Adamson, 1968; Erslev, 1975) suggest a relationship of the form:
Ep = 1  . e-G1 > t0	 (8)*
where E a is the rate of erythropoietin production, P t0 is the tissue
oxygen partial pressure, G 1 is the gain or slope of the function plotted
linearly as In Ep vs. P
t
 0, and Eo is the E p -intercept at Pt
Eo = e	
0 = 0. Setting
t' i , ensures that Equation (8) will always pass through the normal
operating point (E p = 1.0 1 P 
t 
0 = 1.0) irrespective of values of G 1 .	 In
* The bar over the symbols represents normalized values. Thus, X = X/X(o),
where X(o) is the control or pre-treatment condition and X is a value
during the post-control or treatment phase. The use of normalized values
simplified comparison of model response with data from various labora-
tories.
V -- - --
certain cases, it may be desirable to postulate a shift in the normal oper-
ating point as well as gain, and in those cases E  and G 1
 may be adjusted
separately. Figure 3 illustrates the semi-logarithmic relationship between
tissue oxygen tension and erythropoietin production and shows the influence
of G1.
The concentration of erythropoietin in the plasma (E) is a function of
the rate of production (F p ), the rate of clearance or destruction (E d ) and
the vo l ume of distribution (V e ). If it is assumed that the rate of dis-
appearance is proportional to the plasma concentration (i.e. E d = K  x E,
where K  = clearance constant = log e2/plasma half-life), then the following
first order differential equation can be written for the rate of change of
erythropoietin concentration (Reissman, et al, 1965; Mylrea & Abbrecht,
1971):
dt a E- - Ke E	 (9)
e
The steady-state concentration of E (at dE/dt = 0) is, therefore,
F (o) = E p (o)/Ke V e 	(10)
Equation (9) can be normalized by letting E = E/E(o) and F p = Ep/Ep(o)
and substituting Equation (10) into Equation (9):
dE	 log 2
dt = Ke (E p - f) = TEe— ( Ep - E)	 (11)
a form which has the
and further, indepen
since E(o) = Yo).
this does not appear
1962).
advantage of being independent of distribution volume,
Jent of erythropoietin half-life (TE,) at steady-state,
The value of TE, = 12 hours was chosen for humans, but
to be well established for normal subjects (Waldman,
•9	 •1
Red Blood Cell Production
An equation expressing the semi-logarithmic dose-response relationship
between red cell production (RCP) and erythropoietin concentration (E) can
be given as:
kC_ = G2 log e 1 4. P 1
	(12)
As has been the convention, RCP and E have been normalized with respect to
their steady-state control values. G 2 is the gain or slope of the response
curve and P 1 is the value of PUP when E = 1.0, and is normally taken as unity.
The accuracy of Equation (12) may diminish considerably at very low and
very high values of erythropoietin levels. For example, at decreasing values
of F approaching zero, the production rate tends toward minus infinity rather
than zero, while at high E values the relationship does not exhibit a maximal
production which is known to exist. Therefore, two additional equations were
formulated and piecewise fitted to Equation (12) to account for suppressed and
maximal erythropoiesis (see Figure 4). Their precise description is somewhat
speculative, although this bone marrow function curve closely corresponds
to the sigrnoid shape of most biological dose-response relationships (Riggs,
1970) and to those observed by others for the bone marrow (Camiscoli & Gordon,
1970; Gurney, 1962; Dunn, et al, 1977).
in the present study it was assumed that there is no basal production of
red cells unless erythropoietin is present (i.e. P o = 0). Maximal red cell
production is assumed to be six times normal (Mylrea R Abbrecht, 1971) (i.e.
P = 6) and the upper limit of accuracy of Equation (12) was arbitrarily
m	 _
chosen at RCP = 5.
Iron uptake studies of red cells indicates a bone marrow transit time
for red cell production of 3.5 to 4.5 days (Harris & Kellerman, 1970). This
effect was included in the model using a simple first-order time delay* with
a time constant, T BM . The inclusion of this transit delay clearly improved
* If Y is the steady-state value predicted from a dose-response relationship,
then the response delayed with a time constant, T, is obtained by the sol-
ution of the differential equation: T dy/dt + y = Y. 	 In finite difference
form, suitable for iterative computer solution, this becomes:
Y = yl + (Y - y ) (H/T) where H = integration step size, y  = value of y
ai the ith iteration and y 2 = value of y at i+lth iteration.
the realism of the dyndmic response of the model especially followinq
sudden changes in tissue oxygen tension.
Red Cell Destruction and Reif Cell Mass
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the destruction rate of cells.
in which cells are destroyed
a given life span (Berlin,
i)n,(RCD),is simply proportional
If that amount is given as RCM
The life span of the red cell dictates
A model of red cell destruction was assumed
randomly and none of the cells survive past
1964). In that case, the rate of destructi
to the amount of cells present at any time.
then the rate of RBC destruction will be:
RCD = Kr 'RCM - log e2-RCM/TRC,
,,
	(13)
where TRC,	 red cell half-life and K r = red cell clearance constant =
log e2/TRC,. A +	,al values used in the model the rate of red cell
destruction	 1.1 of the total amount present or 22 nil packed cells/day.
The instantaneous change in total circulating red cell mass is the
net difference between red cell production and red cell destruction rates:
d(RCM) = RCP - RCD
t
RCP is obtained from Equation (12) using the transformation RCP=RCP x RCP(o)
where RCP(o) = RCD(o) = K r ' RCM(o).
Finally, the current value of RCM, obtained by integration of Equation
(14), is combined with the plasma volume to obtain the whole-body hemato-
crit of the circulation:
Hct =
	
RPV +U	
(15)
CM 
and the feedback loop is closed.
Model 0 ep ration
The system of Equations (1,2,4-8, 11-15) are solved by computer
simulation using an iterative procedure. Equations (11) aid (14) are
(14)
integrated numerically using a simple Euler algorithm (Arden b Asti 11
1970) acid initial conditions E(o) and kCM(o), respectively. 'The program
is currently implemented on a Univac 1110 and a PDP 11/40 using Fortran.
Remote terminals including graphic display of the simulation responses
(and experimental data simultaneously, when desired) have greatly facil-
itated user interaction, and enhanced convenience of model validation.
Perturbing the model away from its normal steady-state (initial con-
ditions) is accomplished by altering one of the model parameters*. 'These
quantities are normally constant in value, but can be altered during a run
to simulate either independent stress stimuli or long term regulatory
adjustments. Thus, hypoxia may be simulated by decreasing arterial P02
and hemolysis is simulated b., decreasing the red cell life span. Thcse
and other physiological/clinical situations which the model is capable of
simulating, and the major parameters which are involved are summarized in
Table II. In some cases, alteration of more than one parameter may he
desired in the simulation of altitude hypoxia which involves a primary
change in arterial 
P02 
and a compensatory shift in oxy-hemoglobin affinity
(P50). Parameter values may be time-invariant with values fixed prior to
a simulation run or they may be entered as a funct'lon which varies with
time as the run progresses. Experimental data may be used to drive the
model in this fash i on. Thus, it is possible to simulate a wide variety
of stresses and tebt a large number of hypotheses regarding regulating
mechanisms with this model.
Parameter Estimation
Table I lists the values of the system parameters, chos ,n as represen-
tative of the human system. Also shown are the steady-state control values
(;.e. initial conditions) of the major dependent (output) variables. The
precise values of most of the quantities shown in Table I ara not critical,
* The term "parameter" is used to denote time-invariant quantities which
are not altered by the dynamic properties of the model (i.e., see bullet
ended arrows in Figure 1) as opposed to "dependent variables" which are
time-varying and form the connecting links of the feedback circuit
(i.e., ° t0, E, RCP, Hct, etc.).
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however, to the general behavior of the model's response when expressed
in percent deviation from control. An exception to this occurs for the
highly nonlinear functions such as the oxygen equil i brium curves and the
renal and bone marrow function curves. The location of the operating
point on these curves can change the nature of the output response. Also,
the shape of these curves, as defined by the gains and threshold para-
meters, are ciao critical to the magnitude of the response. These will be
discussed next.
An equation for the oxygen equilibrium curve was obtained from Aberman,
et al (1973). Their study included a computer algorithm that converts
oxygen tension to saturation, and with iteration, oxygen saturation to
tension. The agreement between measured and computed values is claimed to
be better than 0.2 01 .	 In addition, the algorithm includes the capability
of altering P50 values.
Analysis of Adamson's (1968) data, trom which the erythropoietin
release function was obtained, leads to an estimated value of G 1 = 2.8.
In our simulation studies of bed rest and hypacia, (Kimzey, et al, 1979;
Leonard, et al, 1979) values of G 2 were determ i ned by parameter estima-
tion to range from 2 to 5. No data exists to confirm these estimates
directly.	 It is, therefore, permissible to use the gain factors as
adjustable parameters, within reasonable limits, in order to test hypo-
theses and possibly provide improved agreement between model and experi-
mental data. In addition to the gains or sensitivities, the other para-
meters of these functions (i.e. E o , P o , P 1 ) which can be thought of as
threshold indices aril also not well known and are available for parameter
estimation during a simulation. Changing these latter quantities implies
a shift of the normal operating points (i.e. (E p= l,P to = 1), RCP=l,E=1)).
The value of K  was obtained from Equation (7) by dividing the oxygen
uptake by the calculated (P v0 - P t0). P 
t 
0 was arbitrarily assumed to be
20 min Hg and P 
v 
0 was computed from Equations (1,2 and a-6).
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CONTROL SYSTEM PROPERTIES OF MODEL
Sensitivity Analysis_
The effect of the model parameters on the overall behavior of the
response can be demonstrated by sensitivity analysis techniques (leonsrd,
1974; Miller, 1976). This is a systematic method of evaluating the rela-
tive importance of different parameters. Steady-state sensitivity coef-
ficients were estimated by varying each of the most important parameters,
one at a time, by small increments around the normal control state as
defined by Table I. Table III lists the percent change in one depen-
dent variable - red cell production rate - caused by a 1" decrease in
the model parameters (shown in left colurm) and determined after a new
steady-state condition was reached. Positive values of these coefficients
indicates a response to at hypoxic condition and negative values indicates
tis',ue hyperoxia. In each case the response is in a direction that agrees
with the concepts of erythropo:esis regulation. The unusually high influ-
ence on erythropoiesis indicated for oxygen uptake and perhaps capillary diffu-
sivity may not be representative of the real intact system (see Discussion).
However, this analysis does support the claim that P50 shifts can dramat-
ically augment tissue oxygenation (Brewer, 1974; Metcalfe dnd Dhindsa, 1972).
A dynamic sensitivity analysis is illustrated in Figure 5. 	 In this
case, the six most important parameters were changed by 10"' in a direction
which would initiate an hypoxic response. The dynamic behavior of four
important dependent system variables during this constant load disturbance
are shown over a period of 30 days. The controller gains used in the sim-
ulations of Table III and Figure 5 were the sauce: G 1 =3 and G2 = 4.	 It is
apparent that the general ranking of parameter importance found in the
steady-state is maintained for the dynamic state as well. Parameter
influence on the steady-state response was found to be relatively insen-
sitive to values of controller gain since doubling gains increases the
sensitivity coefficients of Table III by less than 15;!.. However, sensi-
tivity coefficients do vary more significantly with deviations from the
operating point.	 If, for example, a new equilibrium state was simulated
for a specific hypoxic condition and sensitivity coefficients were
In
obtained by small perturbations from that state, both the magnitude and
ranking of the coefficients may be altered. This is an expected behavior
of nonlinear control systems.	
1.
Figure 5 also illustrates the wide difference in dynamic properties
of various elements in the model. This model may be viewed as having four
sequential processes, each with a characteristic time constant that is
correspondingl;,
 longer: alterations in tissue oxygenation (seconds to
minutes), erythropoietin release (hours), red cell production (days) and
red cell mass (days to months). An interesting prediction of these simu-
lations, is that the dynamics of the hypoxia response is similar for a
variety of constant load disturbances whether it be an increase in plasma
volurne or a decrease in renal flow rate. Unfortunately, the experiments
required to confi rm this conclusion are difficult to perform. These simu-
lations should, therefore, be considered as model-to-model comparisons
which demonstrate that the model responds appropriately in a gross sense.
,Model-to-data comparisons, a more challenging validation process, will be
discussed in another section.
The Renal-Bone Marrow Axis as a Proportional Controller
A more visual understanding of the relationships for renal and bone
marrow function can be obtained by determining the overall dose response
curve of the combined kidney-bone marrow axis; that is, the relationship
between tissue oxy gen tension and red cell production. The results are
shown below only for the mid-range of erythropoietin production and were
obtained by mathematically combining the renal function (E q uation (9)) with
the steady-state plasma distribution function of erythropoietin (Equation
(12); E=E p )) and the bone marrow function (Equation (13)).
	
in this way
erythropoiet-in is eliminated as an explicit variable; i.e.,
RCP	 G(1-Pt)	 for Pt0 <1	 (16)
where
	
G = G 1 x G2
15
This is a simple inverse linear relationship which has previously been
used in the models of Guyton, et al (1972) and Hodgson (1970). 	 In this
form, the gain of the renal-bone marrow (open-loop) system is seen to be
the product of the two gain factors, G 1 and G2 . Similar (although non-
linear) gain-product relationships were obtained for the extrema of hyper-
oxia and maximal hypoxia. The results of this analysis have been plotted
in Figure 6 for a range of values of G. This function represents the
entire controller circuit of tie erythr •opoiesis model. In general, hypoxic
tissue is predicted to have a greater effect on red cell production than
hyperoxic tissue as indicated by the relative slopes. However, at higher
gain factors, the suppression of erythrop3iesis can be considerable for
relatively small increases in tissue oxygenation.
Equation (16) is a typical controller function for a linear propor-
tional control system in which the actuating error signal is the deviation
of P
t
-0 from its control value (i.e. unity) and G is the constant of pro-
portionality or controller gain. The control value of P.0 is taken as an
arbitrary reference standard and is not meant to imply that there is an
internal set point.
	
It becomes clear from this control function that the
primary controlled v?riable is tissue oxygen tension rather than red cell
production, red cell mass or hematocrit which can be considered feedback
variables. The control system always adjusts the feedback variables in
a direction that returns the controlled variable toward normal after an
initial load disturbance (see Figure 5).
The controller gain is a major determinate of the final feedback
compensation following a disturbance and, within limits, the speed at
which a disturbance is corrected. Although increasing the gain increases
the feedback effect, it may be at the sacrifice of an oscillatory approach
to the steady-state. Systems of higher order than this one will tend to
become unstable as controller gain increases. Oscillations in the erythro-
poiesis system are known to occur in special cases and analysis of these
systems in terms of control system theory has proved to be rewarding
(Mackey, 1978; King-Smith and Morley, 1970).
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Steady-State Errors
It is an inherent property of most biological homeostatic mechanisms
in general and proportional control systems in particular that there will	 `p
be at least some residual steady-state deviation from the normal operating
point when the system is disturbed by a constant load. This "steady-state
error" will vary it size depending on the gain of the system and the rr.ag-
nitude of the load disturbance. The sensitivity coefficients of Table 11I,
for example, indicate the steady-state errors of red cell production resul-
ting from small changes in parameter disturbances.
A bass for understanding steady-state errors in the current model is
the follo-. og: At any equilibrium state, the term dRCM/dt in Equation (14)
must be identically zero. Therefore, Equations (13) and (14) imply that at
steady-state, daily red cell production and destruction rates are equal.
Furthermore, if red cell life span is constant, a steady-state alteration
:n red ce l l mass implies a proportionate change in red cell production.
`'ince most load disturbances are accompanied by changes in circulating red
cell mass (i.e. Figure 5) this implies that red cell production and one o-
more of the factors which effect red cell production (including tissue
oxygen tension, erythropcietin, hematocrit, controller gain and set point)
must have incurred a steady-state error, however small. It can be appre-
ciated from Figure 5 that steady-state errors in tissue oxygen tension are
reduced at the expense of larger errors in red cell mass and hematocrit.
Steady-state analysis may also provide insight into the independent
determinants of the controlled variable (Guyton, et al, 1973). The upper
diagram of Figure 7 shows the effect of tissue oxygen tension on red cell
production (i.e. the controller function of figure 6) and the balance
between red cell production and destruction. Feedback control insures
that the various elements of the model are adjusted until the rate of red
cell mass change, dRCM/dt, becomes zero and that steady-state is defined
by this concition.	 It is mathematically permissible to set dRCM/dt to
equal zero and work backward from this point to visualize those factors
that determine tissue oxygen tension (Figure 1, lower diagram). There
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are only two such factors in our model: red cell destruction (which
determines production rate) and the relationship between tissue oxygen 	
t
tension and red cell production. Therefore, only these factors and those
quantities that effect these factors will ultimately determine tissue
oxygen tension. Experimental evidence is severely lacking on the deter-
minates of the shape of the controller function curve, although it appears
that it may be under the influence of neural and biochemical factors (see
Discussion). The factors that are responsible for normal red cell destruc-
tion are also not apparent (Harris & Kellermeyer, 1970). Except for frank
pathology, rates of destruction are generally considered to be a constant
fraction of total circulating red cell mass.
Aside from these experimental shortcomings, it is important to note
that the factors usua l ly agreed to play a role in acute changes of tissue
oxygenation (i.e. blood flow, capillary diffusivity, oxygen uptake, P50,
hematocrit) are not represented between the zero point and the tissue
oxygen point in Figure 7. Therefore, while they may be considered depen-
dent variables in the system, none of them, from a mathematical point of
view, are independent deterrninates of the final level at which the tissue
oxygen tension will stabilize in the steady-state. While dRCM/dt will
always return to its initial zero value, the tissue oxygen tension may
exhibit a steady-state error due to the inherent properties of the control
system in the face of a constant disturbance. However, based on the above
analysis we see that even tissue oxygen tension will return to its initial
value (i.e., zero steady-state error) when both of the following conditions
are satisfied: a) a constant daily rate of red cell destruction, and
b) a constant controller relationship between tissue oxygen tension and
red cell production.
As an example of the last point, a simulation of hypoxia was per-
formed (Fi g ure R) in which arterial oxygen tension was set at some low value
for the entire run and red cell destruction was clamped at its control value
of 22 ml packed cells/day. Tissue oxygen tension decreased and then beaan to
return toward normal as red cell production and hematocrit rose, similar to
the simulations with the intact system shown in Figure 8(A). However, since the
-I
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destruction rate was not permitted to increase, a greater n.-t rate of red 	 1
cells entered the circulation than would have occurred had destruction
rate rose in accord with the mass action law of Equation (13). As a
result tissue oxygen tension continued to rise and red cil l production
rates declined. When the system reached its new steady-state, red cell
production and tissue oxygen tension returned exactly to the pre-hyporic
control conditions in accord with the concepts discussed in the previous
paragraph. This was in spite of an arterial ox_v(ien tension that was still
significantly depressed and at the expense of an hematocrit and circulating
red cell mass that was considerably above normal.
It is perhaps easy to visualize that a primary change in destruction
rate, as in hemolytic anemia, leads to secondary changes in tissue oxygen
tension.	 It is more difficult to conceive of destruction rate being a
determining factor of tissue oxygenation in a stress like hypoxia in which
it appears, at first, that the decreased oxygen loading o f arterial hemo-
globin is the primary stimulus for hypoxia. However, it is important to
distinguish between the initial stimulus of the acute phase in which blood
PO  is controlling and the ultimate stimulus of the steady-state condition
in which destruction rate (and controller function) is controlling. These
conclusions from a theoretical model may warrant further experimental exam-
ination.
The following simulation will illustrate the ability of the control
system to minimize steady-state errors as well as demonstrate the use of
the model to provide insight into a common hematologica disorder.
Hemolytic Anemia: An Exam le_of Steady_ State Control
Hemolytic anemia is a disease characterized by abnormal shortening
of the red cell life span and a tendency to significantly reduce red cell
mass. Many such cases of this disease are "compensated"; that is, accom-
panied by increased red cell production and a near normal blood hemoglobin
concentration (Crosby, 1977).	 It has been claimed that our present under-
standing of erythropoiesis regulation does riot allow an adequate explana-
tion of compensated hemolytic anemia since it is difficult to conceive of
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an appropriate stimulus for red cell production in the face of a near
normal hemoglobin level (Erslev. 1962), The simulations shown in Figure
9, on the other hand, indicate that compensated hemolytic anemia is quite
explicable by normal feedback control mechanisms. Similar conclusions
have been reached by Hodgson (1970).
In this study. the only load disturbance imposed on the model was a
decrease in red cell life span. The model was allowed to achieve a new
equilibrium state before the values shown in Figure 9 were obtained. In
these simulations the limits of maximum production were removed since the
extreme limits of bone marrow reserve may not be firmly established
(Crosby, 1977). These results show that hemoglobin levels can be main-
tained quite close to nor.nal even though life span has decreased signif-
icantly.	 In addition, this can be accomplished by taking advantage of
only a fraction of the reserve capacity of the bone marrow to produce red
cells. Maximal red cell production is not required until hemolysis causes
life span to be reduced to less than 10-15 days. This prediction agrees
well with clinical findings (Harris & Kellermeyer, 1970; p. 518). Compen-
sation falls off sharply when life span is reduced to less than about 30%
of normal.
The difference between a normal, unperturbed hemoglobin concentration
(i.e. N6=1) and the hemolytic hemoglobin concentration is a steady-state
error. As controller gain increases, the effectiveness of the feedback
regulation in maintaining normal hemoglobin concentration improves. Doub-
ling the controller gain, in the range of compensation, decreases the
hemoglobin steady-state error by about 70%. at the expense of a relatively
small incremental increase (less than 10%) in red cell production rates.
The dashed line in Figure 9 is the case of no feedback regulation c;r open
loop control. In this case, it is assumed that red cell production is
constant at its normal value and independent of the degree of hemolysis.
When hemoglobin levels are compensated at 907. normal value, the steady-
state hemoglobin error is about three (for G = 5) to six (for G=20) times
as large without feedback as it is with feedback. This is well within
the regulating range of other physiological control systems (Riggs, 1970).
f^
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It is conceivable that the effective gain of the controller is much
higher than normal in compensated heinelytic anemia due to the possibility
that additional stimulus besides erythropoietin comes from breakdown
products of red cells and also the observation that the size of the stem
cell pool enlarges (Crosby, 1975; Erslev A Silver, 1975). Both of these
factors would cause an effective increase in gain in the model and increase
the degree of compensation more than shown hore.
These simulations do not explai.i fully compensated anemia, but do
suggest that levels of compensation approaching 100% can be reached by
normal feedback regulation operating under high controller gain.
	 It is
interesting to note in this regard that when hemolytic anemia is induced
in experimental animals over a period of many weeks, full compensation is
never apparently reached (Erslev & Silver, 1975: discussion).
kr
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MODEL VALIDATION USING LABORATORY DATA
The sensitivity analyses and simulation of hemolytic anemia pre-
sented above indicates an appropriate behavior of the model in both
equilibrium and dynamic states. However, ultimate credibility of any
model depends on demonstrating a close correspondence with measurements
obtained directly from the real system. Two examples of model validation
are presented below to serve this purpose.
Altitude Hypoxia and Descent
Buderer and Pace (1972) studied the dynamic ch,;nges in red cell mass,
hematocrit and plasma volume in pig-tailed monkeys during six months at
3800 m altitude followed by descent to sea level for three months. Com-
parable data for human subjects were not available. The OEC for monkeys
is similar to that of man (P50=30 irn Hg) and other elements of the model
would not be expected to be fundamentally different, especially if respon-
ses were expressed as normalized values. The major driving function for
the model was an arterial blood oxygen tension of 50 inn Hg and 95 mm Hg for
the altitude and sea level phases, respectively (Rahn R Otis, 1949). The
model's response was adjusted using the bone marrow controller gain, G2,
until a visual "best Fit" was obtained. The comparison of model output
and data are illustrated in Figure 10. The experimentally determined
changes in plasma volume (bottom curve) was also used as a model driver,
but its effect on the overall response was relatively small.
In addition to predicting the measured dynamic changes of red cell
mass and hematocrit, the model was able to predict other system variables
that were not measured such as plasma erythropoietir and red cell produc-
tion-destruction rates. The simulation shows the general sequence of events,
generally assumed to characterize the hypoxic res ponse,includin q : tissue hv-
poxia (not shown), elevated erythropoietin and augmented red cell production
levels which increase the mass of circulating blood cells (Abbrecht &
Littell, 1972; Huff, et al, 1951; Faura, et al, 1969).	 The opposite
scenario for- the descent phase is also shown. The difference between
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production and destruction rates provides a visual indication of the
dynamic behavior of deviation from steady-state. Vie slow approach to
equilibrium at altitude is also evident from the asymptotic nature of the
Measured quantities. Upon return to sea level, the increased hPmatocrit
	 r
serves as a prolonged stimulus for tissue hyperoxia to the extent that
red cell production may be totally inhibited for several weeks.
In order to obtain the agreement with observed results shown in Fig-
ure 10, two different values of overall controller gain were required for
the different phases of the study (G(altitude)=2.2, G(descent)=12). This
wide difference in effective gain may be more apparent than real, and may
reflect other circulatory, ventilatory, and biochemical adjustments that
are known to respond to changing oxygen transport disturbances (finch R
Lenfant, 197?) and which were not included in this simulation. These regu-
latory elements would also be expected to play a role in gradually reducing
tissue hypoxia and thereby produce the dramatic return-toward-control
behavior of erythropoietin, still not understood, typical of short term
altitude exposure (Abbrecht x Litt.ell, 1972; Dunn, et al, 1976). The model,
in its present form, failed to generate this response. Other simulation
studies, beyond the scope of this study. were performed in which increased
fidelity of the hypoxic response was obtained by assuming changes in P50,
capillary diffusivity, arterial oxygen tension due to ventilatory compen-
sation, and increased sensitivity of erythroid producing tissues to erythro-
poietin (Mylrea A Abbrecht, 1973; Dunn, Leonard, R Kimzey, unpublished).
Red Cell infusion
Polycythemia, induced by infusing red cells from a donor, has long
been known to suppress erythropoietin and red cell production of the recip-
ient (Gurney R Pan, 1958). induction of the erythroid-suppressed state by
this procedure in the mouse forms the basis of an erythropoietin bioassay.
One of the few available studies of the long term effects of red cell infu-
sion in humans was reported by Birkhill, et al (1951) who showed that the
suppression of red cell production was directly related to the amount of
red cells infused.
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A simulation of this experiment is illustrated in i'iqure 11. At
the start of the simulation 800 ml red tells were infused. The model was
modified %o tha, the infused red cell mass could be distinqui%hed from the
original circulating Itklss and could di%dppedr• at a 1 ine,tr' rate over • ► period
Of 1?6 days. Analysis of the model's response %hawed that the increased
hem,ltocrlt leads to tissue hyper'oxia. deer •ed%ed reledse of e1'Ythropoietin
and suppression of red cell production. Loss of recipient's red cell mass
contin ►ied until the hematocrit decrease% to a point where erylhropoiesis
returns toward normal ait(I i-, eil(tal to the (I( , %t rut tioit o 	 recil ► ier.t cells.
As production rates continue to rise %Iightly (due to a  hematocrit which
is ,just he low normal) the r •ecittient'srod cell mass rises towards its con-
trol value. The results Suggest. that erythropoiesis i% under the control
of helm tocrit levels and the renal oxygen sensor in thi% instance is behav-
ing a% the "hemoglobinometer" de%cr• ibed by Reutler (11469).
The simulation r'e%uIt% compart , tavorabIy with the experillientaI re%tllts.
both with r•egar'd to ma(lnitude and time course of the changes in hematocrit,
disappearance of infused blood cells, and suppression aml .-covery of the
recipient.% red cell i ►ws%. Allowance should he made for the fact that the
experim-tital study used only two subjects. did not have the ":.curacy that
radio-labeled cells Would hdVV afforded. dlld Wd% hel'f(1 ►'11x'd at a tlllle pr•tOr
to the identifiCation of veythropoietin.
III(- :imllar• ity between tie descent phase tram altitude Of' the previous
simulation .ind the response to red cell infusion should he apparent. In
both cases, the ircre:r%ed hematocr'It contributed it) t iti,ue hyperoxl,t ,ind
erythro-suppression.	 the degree of suppression w, ► , -itch (create ► • tor the
descent phase than for red cell infusion. primarily because of the initial
higher hematocrit levels of the former case. 	 In hoth simulation .-;, a
similar value of Controller' gain (G = 12) was used to obtain the hest f-it
with experimental data. This also compared favorably with the controller
gain value obtained from mice data previously reported by Hodgson (1970).
?a
DISCUSSION
Any conclusions from a study such as this must be tempered with the
fact that a model is not the real system. The model should be judged,
rather. by whether it serves the purpose of providing insight into the
properties ar ►d characteristics of the real system. Since any model is only
as good as the assumptions on which it is based, it is appropriate to
review and justify the most important of these. For convenience, these
remarks will be divided into two categories: the controlled system and the
controller system.
Controlled Syn tem
A major assumption in the controlled system is the description of the
renal oxygen detector. The evidence strongly indicates that the balance
between oxygen supply and demand at intrarenal sites is the primary stimulus
for erythropoietin releatie (Grant and Root, 1952; Krantz b Jacobson, 1970).
furthe nnore, these detector sites must monitor venous or tissue 1 1 0 ? rather
than arterial 1'02
 since anen ► ia nr increased oxygen-hen ►o(1lobin affinity lead
to increased erythropoietin p m.luction without significantly altering
arterial blood oxygen tension (Adamson, et al, 1969; Metcalfe and Dhindsa.
1972; Hodgson, 1970). The receptors sensitive to tissu- 1 1 0? may he those
cells which excrete erythropoietin or its precursor (liaciu, 1970). Tlie
present mu(,'A is in accord with these cor...epts.
It has been suggested that the kidney has unique characteristics that
enables it to function as a sensitive oxygen chemoreceptor arid. in partic-
ular, be responsive to changing hemoglobin levels. The peculiar renal
microcirc:ulation and the uniquely low arteriovenous oxygen difference pro-
vides a gradient of tissue oxygen tension that amplifie s. changes in blood
oxygen delivery (Metcalfe and Dhindsa, 1972; Gordon and Zanjani, 1970). In
addition, the autoregulatory features of the kidney insures that blood flow
and oxygen uptake are effectively stable over a wide range of oxygen
tensions and blood pressures (Aperia, 196E; Selkurt, 1963). Moreover, if
blood flows should be altered, the kidney, in contrast to other organs, will
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exhibit proportionate changes in oxygen uptake (Pitts, 1960). This means
that the ratio, V 
III 
/Q, the only term in which blood flow appears in the
model (Equation 4)), may be relatively constant and renal blood flow would
not be expected to markedly influence tissue oxygenation.
The above discussion suggests that the powerful influence oxygen uptake,
per se,aois found to have in the made' (Figure 5 and Table 111) may be miti-
gated iri the real system by concurrent changes in blood flow. Similarly, it
is poF^Jble that an elevation of Vm ,by whatever cause,promotes tissue
hypoxia and results in local regulatory increases of K d , the effective capil-
lary diffusivity. This is now known to be true for skeletal muscle (Granger,
et al, 1975), but has not been confirmed for ti,2 kidney. Such regulation
would, however, further dampen the effect of oxygen uptake because K  appears
only in the ratio, V irr/Kd , in Equation (7). It may be desirable to add these
local re gulatory effects - between oxygen uptake, blood flow and capillary
diffusivity - to the model. Our current alternate approach 	 to assume they
are constant and to examine their influence, if the data so suggests, in
improving the accuracy of simulation. Under these circumstances, and in
accord with Equations (',, to (1), tissue PO  would be a function of the hemo-
globin concentration of the blood, the arterial oxygen saturation of hemo-
globin, and the shape and position of the OEC (Beutler, 1969).
4	 It should be emp hasized that the site of the intrarenal detector has
not yet been confirmed and that the quantitative aspects of its oxygen
i
	
	 supply-oomand balance (including direct measurement of P t 0) remain unknown.
Justification of this segment of the model is based on indirect
evidence, gross characteristics of the kidney as a whole, and determinants
of tissue oxygenation derived from other tissues.
The use of a steady-state formulation for tissue oxygenation (Equa-
tions 1 - 7) in a dynamic model is justified because, in the well perfused
kidney, equilibrium of oxygen tensior, due to pure convection and diffusion
may be achieved in ''Che order of seconds to minutes following a load distur-
bance. This can be compared to the much slower changes of the erythropoietin
j	 distribution-bone marrow red cell production process. Estimates of true
equilibration times were obtained from the non-steady state version of this
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algorithm (Middleman, 1972; i)uvelIorory, et al, 1973) which was originally
employed in our studies. The steady-state description permitted the use
of a larger integration step size in the numerical algorithms and increased
the speed of solution by several decades without decreasing the accuracy of
the response for the long time periods in which we	 were interested.
Controller System
An accurate description of the relationship governinq erythropoietin
release is not yet available, presumably because of the difficulty in rreas-
uring intrarenal oxygen levels and the uncertainty surrounding the specific
location of the receptor cells. The formulation used to relate tissue
oxygen tension to erythropoietin release is in accord with the study of
Adamson (1968) who found a semilogarithmic inverse relationship between
daily urinary erythropoietin excretion and hernatocrit in humans. A parallel
between urinary and plasma erythropoietin (Krantz & Jacobson, 1970) as well
as between hernatocrit and tissue p0 2 (Thorling & Erslev, 1968) was assumed
in derivinq Equation (8). A similar relationship has been used by Hodgson
(1970), while Parer (1970) has derived a linear relationship and Mylrea &
Abbrecht (1971) have used arterial oxyhemoglobin concentration (i.e.
fib x S a o) rather than tissue oxygen tension as the independent var'able.
At the present time there do not appear to be sufficient data to reveal
the precise shape of this function.
Measurement of plasma erythropoietin has, until recently, been
restricted to levels above basal (Adamson & Finch, 1975). Therefore, no
data are available to confirm the relationship for reduced release rates
of erythropoietin. This region is of particular interest because of the
application of simulation to bed rest, spaceflight dnd related disturbances
in which chronic elevation of hernatocrit follows plasma volume shifts.
There is an abundance of information demonstrating that in experimclital
animals a linear, relationship exists between red cell production and the log
of erythropoietin concentration (Equation 12). This has been observed, for
example, in bioassay animals in whicn doses of erythropoietin are injected
either singularly with iron uptake used as the index of erythropoietic
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activity (Camiscoli & Gordon, 1970; Dunn, et al, 1977) or administered at
frequent interva l s for up to several weeks with production rate expressed
?n terms of increased red cell mass (Gurney, 1962; Van Dyke & Pollycove,
1962). It is reasonable to assume that a similar dose-response relation-
ship exists for the human although confirmatory evidence is lacking.
In vivo estimates of the human function curve, especially for the suppressed
erythropoiesis range will be possible d% erythropoietin becomes available
in large quantities and as more sensitive assay methods for this hormone
are developed.
The shape and position of the renal and bone marrow function curves
have been found to be crucial elements in the control of erythropoiesis in
genera l and the long term control of tissue oxygenation in particular.
Model parameters have been incorporated to dllow for shifts in sensitivi-
ties and thresholds away from the normal operating points. Values of con-
troller sensitivities have not been well established in the human by direct
methods and only to a limited extent in experimental animals (Hodgson, 1970).
Several studies suggest that alterations in these parameters occur during cer-
tain physiological stresses such as dehydration and hypoxia (Dunn R Lange,1979;
Kretchmar, 1966), and pathological disturbances such as abnormal hemoglobin
(Adamson, et al, 1969). erythrocytosis (Adamson,1968) and hemolytic anemia
(Erslev & Sil 3er,1975). It ap pears that the rate of red cell production is
determined not only by the concentration of erythropoietin, but also by the
site of the stele cell pool (Lajtha, et al, 1962). If this is true, the bone
marrow response to a given dose of erythropoietin should be greater than
normal (i.e. an effective increase in G 2 ). The availability of iron to
the erythron may also influence this function (Finch, et al, 1910). Certain
hormones, such as androgens, as well as neural stimuli, are assumed to exert
their effect on erythropoiesis by their modification of erythropoietin
release (i.e. an effective change in G 1 ; Peschle, et al, 1975; Baciu, X970).
It is possible, using the present model, to p redict these p arameters within
narrow limits provided both the dynamic behavior of er y thropoietin and red
cell production rates are measured simultaneously during a hematologic
stress. Unfortunately, such data are seldom available, especially for
humans.
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Conclusions
We have demonstrated the validity of a human model for the control of
erythropoiesis based on the balance between oxygen supply and demand at the
kidneys which serves as an oxygen receptor and erythropoietin producer.
Validation studies included simulations of experimental nypoxia and hyper-
oxia and a pathological disorder. 	 Feedback regulation of tissue oxygen
tension is accomplished solely by adjustments of hemoglobin levels resulting
f rom the output of a renal-bone marrow controller. Other parameters that
are known to affect acute changes in tissue oxygenation are incorporated
explicitly in the model, but are non-regulatory in nature, and can be
altered manually to test various hypotheses. Similarly, the characteristics
of the controller can also be adjusted to test their effect on long term
control of tissue P02 and red cell mass. We have not found such parameter
adjustment: (other than for the primary disturbance) essential, in most
cases, to simulate the basic behavior of the dynamic and steady-state
response. However, fine tuning of parameters is required to scale the model
output and achieve closer agreement with experimental values. In some cases,
our studies indicate the need to propose additional regulatory elements to
provide, for example, a more realistic simulation of the erythropoietin
response to hypoxia. Other features of a general nature have also been
identified that will increase the utility of the model even further includ-
ing: a) the effect of blood volume and viscosity on oxygen transport, and
b) a description of stem cell kinetics and reticulocytosis.
Obviously, in this limited study, we have been able only to examine a
small fraction of the hematological conditions, experiments, and clinical
syndromes which the model can theoretically simulate. It would not be
realistic to claim, a priori, that the model is accurate for conditions f,ar
which it has not been tested. To the contrary, an important objective in
developing this model was to provide an additional research tool that can
achieve the required realism only by an iterative process between labora-
tory ex perimentation and model refinement. In this manner, the model can
be quite useful in several ways: a) identification of important para-
meters and their sensitivity on the overall system, b) a method to test
L__
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hypotheses rapidly, c) identification ofof specific elements that must be
experimentally quantified, and d) prediction of the behavior of certain
unmeasured or difficult to measure quantities. This approach has already
proven effective for such ground-based studies related to spaceflight as
bed rest and dehydration (Kimzey, et al, 1979; Leonard, et al, 1979). The
model, therefore, becomes a physical framework in which many kinds of
diverse experimental and clinical findings may be incorporated res ►ilting,
hopefully, in a more consistent picture of erythropoietic control.
TABLE I
PARAMETERS AND INITIAL CONDITIONS
Parameters
S,-nbol_ Definition Value Units
CHbO Carrying capacity of hemoglobin 1.34 ml 02/gm fib
E 
Intercept of erythropoietin function 20.09 x normal
G 1 Gain of erythropoietin function 3 non-dimensional
G 2 Gain of red cell	 production function 2 non-dimensional
K 
Capillary diffusivity 0.567 ml	 02 /min-mn lig
MCHC Mean corpuscular hemoglobin concentration 0.375 gm Hb/ml	 RBC
P 0 Oxygen tension	 in arterial	 blood 95.0 fill) Hg
a
PV Plasma Volume 3.0 liters
Pm Maximum production rate of red cells 6 x Normal
Po Minimum production rate of red cells 0 x Normal
P 1 Normal production rate of red cells 1 x Normal
P50 Oxygen tension of hemoglobin at 50%
saturation 26.7 mm I q
Q Renal	 blood flow 1.2 liter/min
TBM Bone marrow transit time 4 days
TES Plasma half-life of erythropoietin 12 hours
TRC, Red cell	 half-life 63 days
Vm Oxygen uptake of kidneys 20 m109/min
Initial Conditions
C 
a 
0	 Oxygen content of arterial blood	 19.6	 ml 0 2 /100 nil blood
C 
v 
0	 Oxygen content of venous blood 	 17.9	 ml 0 2 /100 ml blood
E	 Erythropoietin concentration in p1 p. sma	 1.0	 x Normal
TABLE I (Continued)
Symbol Definition Value Units
E p Erythropoietin production rate 1.0 x Normal
Hct Hematocrit 40 ml	 packed red cells/
100 ml
	 blood
P 
t 
0 Oxygen tension in renal	 tissue fluid 20 mm lig
P 0 Oxygen tension in venous blood 55.3 nm lig
v
RtM Red cell mass 2.0 liters
RCP Production rate of new red blood cells 22 nil	 packed cells/day
S d0 Saturation of arterial	 hemoglobin with
oxygen 91.6 percent
S 0 Saturation of venous hemoglobin with
v
oxygen 89.3 percent
Note,	 a) Units expressed here are not necessarily those used in model.
b) Bar over symbol denotes quantity normalized with respect to
initial value.
c) Symbol followed by(o) as used in text denotes initial condition
or steadv-state value.
J
TABLE II
MODEL PARAMFTERS AND EVENTS WHICH THEY INFLUENCE
c•2 c„hPly
MCHC
Red Cell Life Span
Initial Red Cell Mass
PHYSIOLOGICAL/CLINICAL EVINT
INFLUENCING CHANGE IN PARAMETER
Hypo-/Hyper Thyroidism, Starvation,
Metabolic Activity, Rena l Blood Flow
Abnormal 111) Synthesis, RC M(.mbrane
Disorders
Blood Temperature, pH, 3:.se Excess,
2,3-DPG, abnormal Hb
Sickle Cell Anemia, Carbon Monoxide
Poisoning
Po-tural Change, Exercise, Hemorrhage
Hypoxia, Hyperoxia, Lung Obstruction
Hypoxia, Tissue autorequlation
Bed Rest, Wvightlessness, Dehydration,
Hemorrhage, Infusions
Hemolytic Anemias, Hyperoxia, Abnormal
Hemoglobin
Hypoxia, Acute eryt.hrogenic stresses
Renal and Bone Marrow Tumors and
Insufficiencies, Iron Deficiency,
Ineffective Erythropoiesis, Polycythemia
Vera, Ahlastic Anemia, Hemolytic Anemia
Transfusions, Hemorrhage
PARAMETER
0
?
 
Demand
- H b-02 Affinity
- Hb-02 Carrying Capacity
- Renal Blood Flow
- Arterial PO 
- Capillary Diffusivity
- Plasma Volume
Bone Marrow Time Delay
Controller Gain and Threshold
TABLE III
STEADY-STATE SENSITIVITY ANALYSIS*
PARAMETER
Oxygen Demand, V 
Ol - fib Affinity, P50
Capillary Diffusivity, K 
Blood Flow,
Mean Corpuscular
hemoglobin Concentration, MCHC.
Hemoglobin 0 2 Carrying Capa;.ity,
CHbO
Arterial 02 Tension, Pao
Plasma Volume, PV
Red Cell Half-life, TRHI.
ConCroller Gain, G
% RED CELL PRODUCTION
- 4.55
+ 3.90
+ 3.25
+ 1.45
+ 1.45
+ 1.45
+ 1.10
- 0.90
+ 0.85
- 0.03
* Values shown are % change in red cell production at steady-state clue
to a 1% decrease in parameter value.	 (G=12)
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